4.6 Article

Transcriptome analysis reveals increased abundance and diversity of opportunistic fungal pathogens in nasopharyngeal tract of COVID-19 patients

Related references

Note: Only part of the references are listed.
Article Microbiology

Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells

Judith Grau-Exposito et al.

Summary: We developed a rapid platform for studying SARS-CoV-2 by using primary human lung tissue cells directly, which can identify viral targets, express viral entry factors, and screen viral entry inhibitors and anti-inflammatory compounds. The method preserves main immune and structural cell populations, including the most susceptible cell targets for SARS-CoV-2, and maintains the expression of proteins involved in viral infection. Additionally, the method allows for highly reproducible antiviral testing and provides the identification of new compounds missed by conventional systems like VeroE6.

PLOS PATHOGENS (2023)

Review Virology

A systematic review on SARS-CoV-2-associated fungal coinfections

Shringika Soni et al.

Summary: The severe pandemic of COVID-19 has led to an increase in cases of black fungus coinfection, with patients with diabetes, hyperglycemia, and compromised immune systems at higher risk. Further studies are needed to identify potential risk factors and optimize diagnostic methods to prepare for future outbreaks.

JOURNAL OF MEDICAL VIROLOGY (2022)

Review Immunology

COVID-19 associated with pulmonary aspergillosis: A literature review

Chih-Cheng Lai et al.

Summary: Co-infections of Aspergillus spp. in patients with COVID-19, especially in severe/critical cases, have been reported with incidence ranging from 19.6% to 33.3%. Acute respiratory distress syndrome and high mortality rates are common complications, while early diagnosis through fungus culture and galactomannan testing is crucial for appropriate management. Vigilance and aggressive microbiological studies are recommended for severe/critical COVID-19 patients to detect pulmonary aspergillosis promptly.

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2021)

Article Infectious Diseases

Comprehensive annotations of the mutational spectra of SARS-CoV-2 spike protein: a fast and accurate pipeline

Mohammed Shaminur Rahman et al.

Summary: The SARS-CoV-2 virus is evolving rapidly with unique mutations and amino acid substitutions identified in the spike protein; extensive analysis of protein-coding sequences revealed diverse mutations and deletions, providing insights into potential impacts on virulence; the study presents a custom pipeline for accurate mutation analysis and highlights the importance of tracking viral evolution for future surveillance.

TRANSBOUNDARY AND EMERGING DISEASES (2021)

Article Genetics & Heredity

Diversity and genomic determinants of the microbiomes associated with COVID-19 and non-COVID respiratory diseases

M. Nazmul Hoque et al.

Summary: Analysis of microbiome diversity and genomic features in COVID-19 and non-COVID (COPD and URTI) samples can help in developing microbiome-based diagnostics and therapeutics for respiratory diseases. Future studies should explore microbiome dynamics and host-microbiome interactions using larger sample sizes from diverse ethnic groups and geoclimatic conditions.

GENE REPORTS (2021)

Article Infectious Diseases

Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome

Tommaso Bardi et al.

Summary: Co-infection of bacteria and fungi is common in ICU-admitted COVID-19 patients and usually presents as a severe form of infection, associated with a high mortality rate and longer ICU stay.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2021)

Article Gastroenterology & Hepatology

Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19

Yun Kit Yeoh et al.

Summary: This study found that the gut microbiome composition was significantly altered in patients with COVID-19 compared to non-COVID-19 individuals, regardless of medication received. Certain gut commensals known for their immunomodulatory potential were underrepresented in patients and remained low even after disease resolution. Additionally, the altered gut microbiome composition correlated with disease severity and elevated levels of inflammatory cytokines and blood markers.
Article Infectious Diseases

Characterization and outcome of invasive infections due to Paecilomyces variotii: analysis of patients from the FungiScope (R) registry and literature reports

Rosanne Sprute et al.

Summary: Infections caused by P. variotii are life-threatening, especially in immunocompromised patients with indwelling devices. Peritoneal catheters and prosthetic heart valves are common factors associated with infection. Treatment with systemic antifungals such as Amphotericin B, itraconazole, and posaconazole is effective, while surgical debridement and removal of indwelling devices are important for a favorable outcome.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)

Article Genetics & Heredity

The Species-Specific Acquisition and Diversification of a K1-like Family of Killer Toxins in Budding Yeasts of the Saccharomycotina

Lance R. Fredericks et al.

Summary: Antifungal killer toxins produced by Saccharomyces yeasts are mainly encoded by cytoplasmic double-stranded RNAs (dsRNAs) instead of the DNA genome. A new dsRNA-encoded killer toxin, K1-like (K1L), with unique antifungal activity was identified in Saccharomyces yeasts, related to the canonical K1 killer toxin. The common ancestry of K1L and its homologous killer toxins suggests gene transfer via dsRNAs and DNAs between different yeast species for niche competition.

PLOS GENETICS (2021)

Review Biotechnology & Applied Microbiology

The Role of Bacterial and Fungal Human Respiratory Microbiota in COVID-19 Patients

Saber Soltani et al.

Summary: Recent studies have shown that the microbiota of COVID-19 patients may be altered, potentially impacting immune function and disease progression. While current research primarily focuses on gut microbiota, it is essential to also consider the lung microbiota in COVID-19 patients. This study aims to review respiratory microbiota dysbiosis among COVID-19 patients to encourage further exploration of the interaction between SARS-CoV-2 and respiratory microbiota.

BIOMED RESEARCH INTERNATIONAL (2021)

Article Multidisciplinary Sciences

Freeze-dried Nannochloropsis oceanica biomass protects eicosapentaenoic acid (EPA) from metabolization in the rumen of lambs

Ana C. M. Vitor et al.

Summary: The study demonstrates that FD N. oceanica biomass is a natural rumen-protected source of EPA for ruminants, increasing EPA concentration in the rumen and affecting the ruminal biohydrogenation of C18 fatty acids.

SCIENTIFIC REPORTS (2021)

Article Multidisciplinary Sciences

SARS-CoV-2 infection reduces human nasopharyngeal commensal microbiome with inclusion of pathobionts

M. Nazmul Hoque et al.

Summary: This study revealed that infection with SARS-CoV-2 can cause significant dysbiosis in the human nasopharyngeal microbiome, characterized by an increase in opportunistic bacterial species and a decrease in commensal species. These features may provide insights for developing microbiome-based diagnostics and therapeutics for the novel coronavirus disease.

SCIENTIFIC REPORTS (2021)

Article Multidisciplinary Sciences

Microbiome signature and diversity regulates the level of energy production under anaerobic condition

M. Shaminur Rahman et al.

Summary: The microbiome of anaerobic digester is crucial in regulating energy production, with different stages of anaerobic digestion showing distinct microbial diversity. The study identified specific indicator species and genomic features related to energy production, with archaea showing a positive correlation with important parameters like digester pH and CH4 concentration. Genomic functional activities related to energy production were enhanced in microbiomes with the highest level of CH4 production, suggesting a strong correlation between microbial composition and functionality in anaerobic digestion.

SCIENTIFIC REPORTS (2021)

Review Infectious Diseases

COVID-19-associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic's second wave in India

Jesil Mathew Aranjani et al.

Summary: The second wave of COVID-19 in early 2021 has caused devastating chaos in India, with a sudden surge of mucormycosis in COVID-19 patients presenting a major challenge. Diabetic patients are more susceptible to this fungal infection, and treatment strategies primarily involve surgical debridement and antifungal therapy.

PLOS NEGLECTED TROPICAL DISEASES (2021)

Review Multidisciplinary Sciences

Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis

Jackson S. Musuuza et al.

Summary: Our study found that as many as 19% of patients with COVID-19 had co-infections and 24% had superinfections. The presence of either co-infection or superinfection was associated with poor outcomes, such as increased mortality.

PLOS ONE (2021)

Article Biochemical Research Methods

Nasopharyngeal Microbiota in SARS-CoV-2 Positive and Negative Patients

Phillip A. Engen et al.

Summary: The study revealed significant differences in nasopharyngeal microbial community structure between COVID-19-positive and -negative patients, providing preliminary evidence for the relationship between SARS-CoV-2 infection and microbial communities.

BIOLOGICAL PROCEDURES ONLINE (2021)

Article Immunology

Microbial co-infections in COVID-19: Associated microbiota and underlying mechanisms of pathogenesis

M. Nazmul Hoque et al.

Summary: The ongoing devastating COVID-19 pandemic caused by SARS-CoV-2 has resulted in a complex molecular pathogenesis involving a variety of microbial domains, leading to worsened conditions in critically ill patients that has not been extensively reviewed. Co-infections with bacteria are predominant, with the incidence potentially up to 94.2% in laboratory-confirmed cases, impacting diagnosis, treatment, and prognosis of COVID-19.

MICROBIAL PATHOGENESIS (2021)

Article Immunology

Gut Microbiota Dysbiosis Correlates with Abnormal Immune Response in Moderate COVID-19 Patients with Fever

Yaya Zhou et al.

Summary: This study revealed the difference in gut microbiota composition between moderate COVID-19 patients with and without fever. Patients with fever showed enrichment of potential pathogens, while those without fever had higher levels of anti-inflammatory and protective bacteria.

JOURNAL OF INFLAMMATION RESEARCH (2021)

Review Public, Environmental & Occupational Health

Mucormycosis: A deadly black fungus infection among COVID-19 patients in India

Naveen Kumar Choudhary et al.

Summary: After the first phase of Covid-19, Indians are facing a new challenge of mucormycosis, also known as black fungus. The use of immunosuppressants to treat Covid-19 has been identified as a risk factor for getting infected with mucormycosis. Early diagnosis, removal of predisposing factors, timely antifungal therapy with surgical removal of infected tissues are crucial in eradicating mucormycosis.

CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH (2021)

Review Respiratory System

The role of co-infections and secondary infections in patients with COVID-19

Charles Feldman et al.

Summary: The current review provides an extensive look at the prevalence of co-infections and superinfections in patients with COVID-19, highlighting their potential impact on the severity and outcome of the disease. However, a clear distinction between the two types of infections is often lacking in the literature.

PNEUMONIA (2021)

Article Chemistry, Multidisciplinary

Considering the Effects of Microbiome and Diet on SARS-CoV-2 Infection: Nanotechnology Roles

Kourosh Kalantar-Zadeh et al.

ACS NANO (2020)

Article Gastroenterology & Hepatology

Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization

Tao Zuo et al.

GASTROENTEROLOGY (2020)

Letter Medicine, General & Internal

SARS-CoV-2 and influenza virus co-infection

Elena Cuadrado-Payan et al.

LANCET (2020)

Letter Biochemistry & Molecular Biology

The proximal origin of SARS-CoV-2

Kristian G. Andersen et al.

NATURE MEDICINE (2020)

Review Immunology

Malasseziaspp. Yeasts of Emerging Concern in Fungemia

Wafa Rhimi et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)

Review Microbiology

Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection

Lirong Bao et al.

FRONTIERS IN MICROBIOLOGY (2020)

Review Biochemistry & Molecular Biology

Bacterial co-infections withSARS-CoV-2

Rasoul Mirzaei et al.

IUBMB LIFE (2020)

Article Virology

Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China

Guqin Zhang et al.

JOURNAL OF CLINICAL VIROLOGY (2020)

Review Virology

Gut microbiota and Covid-19-possible link and implications

Debojyoti Dhar et al.

VIRUS RESEARCH (2020)

Article Multidisciplinary Sciences

Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity

M. Rafiul Islam et al.

SCIENTIFIC REPORTS (2020)

Article Multidisciplinary Sciences

Prevalence of Malassezia species on the skin of HIV-seropositive patients

Pawel Krzysciak et al.

SCIENTIFIC REPORTS (2020)

Review Endocrinology & Metabolism

A metabolic handbook for the COVID-19 pandemic

Janelle S. Ayres

NATURE METABOLISM (2020)

Review Agriculture, Dairy & Animal Science

Red yeast (Phaffia rhodozyma) as a source of Astaxanthin and its impacts on productive performance and physiological responses of poultry

H. A. M. Elwan et al.

WORLDS POULTRY SCIENCE JOURNAL (2019)

Article Biochemistry & Molecular Biology

New approach for understanding genome variations in KEGG

Minoru Kanehisa et al.

NUCLEIC ACIDS RESEARCH (2019)

Article Infectious Diseases

Impact of microbial Aetiology on mortality in severe community-acquired pneumonia

Jessica Quah et al.

BMC INFECTIOUS DISEASES (2018)

Article Infectious Diseases

Saccharomyces cerevisiae Laryngitis and Oral Lesions in a Patient with Laryngeal Carcinoma

Jumanah N. Algazaq et al.

CASE REPORTS IN INFECTIOUS DISEASES (2017)

Review Infectious Diseases

Previously unknown species of Aspergillus

M. Gautier et al.

CLINICAL MICROBIOLOGY AND INFECTION (2016)

Review Biochemistry & Molecular Biology

The emerging world of the fungal microbiome

Gary B. Huffnagle et al.

TRENDS IN MICROBIOLOGY (2013)

Article Ecology

Undersampling and the measurement of beta diversity

Jan Beck et al.

METHODS IN ECOLOGY AND EVOLUTION (2013)

Review Immunology

Immunity to fungal infections

Luigina Romani

NATURE REVIEWS IMMUNOLOGY (2011)

Article Nutrition & Dietetics

Preliminary Clinical Evaluation of Toxicity and Efficacy of A New Astaxanthin-rich Haematococcus pluvialis Extract

Akira Satoh et al.

JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2009)